Details for New Drug Application (NDA): 075239
✉ Email this page to a colleague
The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
Summary for 075239
Tradename: | LABETALOL HYDROCHLORIDE |
Applicant: | Hospira |
Ingredient: | labetalol hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 075239
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 075239
Suppliers and Packaging for NDA: 075239
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075239 | ANDA | Hospira, Inc. | 0409-2339 | 0409-2339-34 | 10 CARTON in 1 PACKAGE (0409-2339-34) / 1 CARTRIDGE in 1 CARTON / 4 mL in 1 CARTRIDGE (0409-2339-24) |
LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075239 | ANDA | Cardinal Health 107, LLC | 55154-4747 | 55154-4747-5 | 5 CARTRIDGE in 1 BAG (55154-4747-5) / 4 mL in 1 CARTRIDGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
Approval Date: | Nov 29, 1999 | TE: | AP | RLD: | No |
Complete Access Available with Subscription